Does the enterolactone (ENL) affect fatty acid transporters and lipid metabolism in liver?

• Published in: Nutrition & metabolism Vol. 14; no. 1; p. 69
• Main Authors: Drygalski, Krzysztof, Berk, Klaudia, Charytoniuk, Tomasz, Iłowska, Nicoletta, Łukaszuk, Bartłomiej, Chabowski, Adrian, Konstantynowicz-Nowicka, Karolina
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 13.11.2017; BioMed Central; BMC
• Subjects: Carrier proteins; Liquid chromatography; Liver diseases; Metabolites; Obesity; Physiological aspects; Polyphenols; Saturated fatty acids; Type 2 diabetes
• ISSN: 1743-7075; 1743-7075
• DOI: 10.1186/s12986-017-0223-1

NAFLD as a result of inappropriate diet and obesity, may progress to sever conditions such as: type 2 diabetes mellitus or steatohepatitis, and has recently become a prevalent topic of numerous investigations. Due to its dangerous aftermaths, finding new substances, such as polyphenols and their derivatives, which might reduce liver steatosis is the main target of research into NAFLD treatment. Hence, the aim of the present study was to evaluate the effect(s) of enterolactone (ENL), a metabolite of secoisolariciresinol (SECO), on lipid metabolism together with changes in the expression of fatty acid transporters in fatty liver. The experiments were conducted on HepG2 cells incubated with either ENL and/or palmitic acid during 16 h exposure. The expression of selected fatty acid transport proteins: FATP2, FATP5, CD36, FABPpm, ABCA1, MTP, ACBP and L-FABP, as well as the proteins directly involved in lipogenesis (FAS), oxidation pathway (CPT 1), and lipid metabolism (PPARα, LXR, SREBP1c, pAMPK) was estimated by Western Blot. Intra and extracellular lipid contents were assessed by Gas-Liquid Chromatography. The data was analyzed with two-way analysis of variance (ANOVA), and results were considered to be statistically significant at  ≤ 0.05. ENL stimulated extracellular efflux of free fatty acids (FFA) and triacylglicerols (TAG) to the medium, while, it had no influence on FATP-family mediated intracellular fatty acid uptake. Moreover, ENL decreased the expression of CPT 1, pAMPK, PPARα, increased SREBP1c and had no effect on LXR, and FAS content. The findings of our study demonstrate that ENL had opposite effect on liver steatosis in comparison with other polyphenols what suggests that it may be an inactive metabolite. ENL did not affect significantly the intracellular accumulation of FFA, DAG and TAG, yet it promoted their extracellular efflux. Furthermore, it inhibited ß-oxydation and intracellular lipid metabolism what may contribute to the progression of NAFLD.